» Authors » Joey Wee-Shan Tan

Joey Wee-Shan Tan

Explore the profile of Joey Wee-Shan Tan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 120
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao J, Ong C, Srivastava S, Chia D, Ma H, Huang K, et al.
Gastroenterology . 2024 Aug; 167(7):1384-1398.e4. PMID: 39147169
Background & Aims: Peritoneal metastasis (PM) in gastric cancer (GC) is associated with poor prognosis and significant morbidity. We sought to understand the genomic, transcriptomic, and tumor microenvironment (TME) features...
2.
Chong Y, Thiagarajan S, Tan Q, Lim H, Tan J, Hendrikson J, et al.
Sci Rep . 2024 Jul; 14(1):17522. PMID: 39080370
Peritoneal metastasis (PM), the regional progression of intra-abdominal malignancies, is a common sequelae of colorectal cancer (CRC). Immunotherapy is slated to be effective in generating long-lasting anti-tumour response as it...
3.
Seo C, Tan J, Farid M, Wong J, Soo K, Chia C, et al.
PLoS One . 2024 Apr; 19(4):e0300594. PMID: 38574044
Background: Peritoneal sarcomatosis (PS) is a difficult entity to treat with limited options and guarded prognosis. We aimed to determine if the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) could offer...
4.
Murugan T, Wong L, Ong X, Tan S, Tan J, Liu Y, et al.
Ann Surg Open . 2023 Dec; 4(4):e339. PMID: 38144489
Objective: To examine the association between the performance of mapping biopsies and surgical outcomes postexcision of extramammary Paget's disease (EMPD). Background: Primary EMPD is a rare entity associated with poorly...
5.
Paik B, Seo C, Tan J, Juan W, Soo K, Ong C, et al.
Front Oncol . 2022 Aug; 12:891710. PMID: 36033535
Retroperitoneal liposarcomas (RPLPSs) are a rare tumor group for which current guidelines recommend aggressive resection to attain microscopically negative (R0) margins. To ensure R0 margins, resection of adherent or adjacent...
6.
Liu Y, Ng W, Zhu H, Tan Q, Hendrikson J, Tan J, et al.
STAR Protoc . 2022 Jul; 3(3):101548. PMID: 35842864
Clinically relevant animal models are crucial for effective development of therapeutics for peritoneal carcinomatosis (PC). This protocol describes the generation of patient-derived ascites-dependent xenograft (PDADX) models from the cellular component...
7.
Li Z, Wong L, Sultana R, Lim H, Tan J, Tan Q, et al.
Pleura Peritoneum . 2022 Jul; 7(2):39-49. PMID: 35812010
Background: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has recently emerged as a palliative alternative for patients with unresectable peritoneal metastasis (PM). Quality of life (QoL) has increasingly been used as an...
8.
Hendrikson J, Liu Y, Ng W, Lee J, Lim A, Loh J, et al.
Cell Rep Med . 2022 Mar; 3(2):100526. PMID: 35243423
Peritoneal carcinomatosis (PC) present a ubiquitous clinical conundrum in all intra-abdominal malignancies. Via functional and transcriptomic experiments of ascites-treated PC cells, we identify STAT3 as a key signaling pathway. Integrative...
9.
Yap D, Wong J, Tan Q, Tan J, Chia C, Ong C
Front Oncol . 2021 Dec; 11:795390. PMID: 34926311
Background: Peritoneal metastasis (PM) is a late-stage manifestation of intra-abdominal malignancies. The current standard of care indicates that cure can only be achieved with cytoreductive surgery (CRS) which is often...
10.
Wong L, Li Z, Fan Q, Tan J, Tan Q, Wong J, et al.
Eur J Surg Oncol . 2021 Oct; 48(3):640-648. PMID: 34716035
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) play an important role in the treatment of various peritoneal surface malignancies, but its efficacy in peritoneal sarcomatosis (PS) remains unknown. Hence,...